Epigenomics Finally Gains FDA Approval For Epi proColon Blood Test
Executive Summary
Epigenomics has finally gained US FDA approval for its Epi proColon noninvasive colorectal cancer screening test, ending what has been a long, obstacle-filled journey for the German-US molecular diagnostics company.